High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

Saved in:
Bibliographic Details
Published inBlood Vol. 131; no. 18; pp. 2086 - 2089
Main Authors Schrader, Anne M.R., Jansen, Patty M., Willemze, Rein, Vermeer, Maarten H., Cleton-Jansen, Anne-Marie, Somers, Sebastiaan F., Veelken, Hendrik, van Eijk, Ronald, Kraan, Willem, Kersten, Marie José, van den Brand, Michiel, Stevens, Wendy B.C., de Jong, Daphne, Abdul Hamid, Myrurgia, Tanis, Bea C., Posthuma, Eduardus F.M., Nijland, Marcel, Diepstra, Arjan, Pals, Steven T., Cleven, Arjen H.G., Vermaat, Joost S.P.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 03.05.2018
Subjects
Biomarkers, Tumor
Biopsy
CD79 Antigens - genetics
Humans
Immunohistochemistry
Lymphoma, Large B-Cell, Diffuse - diagnosis
Lymphoma, Large B-Cell, Diffuse - genetics
Lymphoma, Large B-Cell, Diffuse - mortality
Mutation
Myeloid Differentiation Factor 88 - genetics
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Undefined-2
ObjectType-Article-3
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2017-12-822817